Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuing Care01:25

Continuing Care

1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

517
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
517
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Palliative neurology].

Die Anaesthesiologie·2024
Same author

Quantitative analysis of the impact of infectious disease physicians on patients in the emergency department fast-track parenteral antibiotics program.

BMC infectious diseases·2024
Same author

Performance of commercial growing-finishing pigs fed supplemental isoquinoline alkaloids: a statistical process control analysis.

Porcine health management·2023
Same author

Identification of risk factors for postoperative delirium in patients following intraoral reconstruction with microvascular free flaps: a matched-pair analysis.

International journal of oral and maxillofacial surgery·2023
Same author

Perfusion of microvascular free flaps in head and neck reconstruction after prior neck dissection and irradiation.

International journal of oral and maxillofacial surgery·2022
Same author

European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines.

European stroke journal·2021
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.2K

[Palliative neurology].

K Amadori1,2, T Steiner3,4

  • 1Klinik für Altersmedizin, varisano Klinikum Frankfurt Höchst, Gotenstraße 6-8, 65929, Frankfurt am Main, Deutschland. kerstin.amadori@varisano.de.

Der Nervenarzt
|July 18, 2024
PubMed
Summary
This summary is machine-generated.

Neuropalliative care addresses the complex needs of patients with incurable neurological diseases, improving quality of life. Enhanced neurologist training in palliative care is crucial for effective symptom management and end-of-life support.

Keywords:
Assisted suicideBiomedical ethicsMultiprofessional teamPalliative medicineSymptom control

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.6K
Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
06:13

Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain

Published on: March 1, 2024

889

Related Experiment Videos

Last Updated: Jun 20, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.2K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.6K
Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
06:13

Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain

Published on: March 1, 2024

889

Area of Science:

  • Neurology
  • Palliative Medicine

Background:

  • Palliative medicine offers holistic care for the terminally ill, focusing on quality of life and suffering alleviation.
  • Neurological diseases often present complex symptoms, long trajectories, and poor prognoses, necessitating early palliative care.
  • Current palliative care provision for neurological conditions is often inadequate.

Purpose of the Study:

  • To highlight the need for qualified neuropalliative care.
  • To outline essential competencies for neurologists in palliative care.

Main Methods:

  • Review of palliative medicine principles and their application in neurology.
  • Identification of core competencies for neurologists in palliative care.

Main Results:

  • Neuropalliative care requires intensified interdisciplinary collaboration.
  • Neurologists need specific skills in team-orientation, communication, symptom control, and end-of-life ethics.

Conclusions:

  • Qualified neuropalliative care is essential for patients with incurable neurological diseases.
  • Integrating palliative care competencies into neurology training is vital to meet patient needs.